Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Clinical

  • 1
    News

    Thyroid hormone analogues can reverse NASH

    April 27, 2021

    In patients with nonalcoholic steatohepatitis (NASH) and stages 1-3 fibrosis, does the thyroid hormone receptor beta-agonist, resmetirom reduce hepatic steatosis compared with placebo?

  • 1
    News

    Efficacy and safety of daily low-dose colchicine after recent MI

    April 26, 2021

    Can giving low-dose colchicine to patients after a recent myocardial infarction reduce future ischemic cardiovascular events, compared with placebo?

  • 1
    News

    Feds lift pause of J&J COVID vaccine, add new warning

    April 23, 2021

    The warning is directed at women under the age of 50.

  • 1
    News

    Study: COVID-19 can kill months after infection

    April 23, 2021

    The risk of death is increased up to 6 months after they catch the virus.

  • News

    Can we get to ‘COVID zero’? Experts predict the next 8 months

    April 23, 2021

    “Right now, we are projecting the United States all the way to Aug. 1 [will have] 619,000 deaths from COVID-19, with 4.7 million globally,” said Ali H. Mokdad, PhD.

  • 1
    News

    Lower target LDL-C cuts risk of CV events in ischemic stroke patients

    April 23, 2021

    Is a target LDL cholesterol (LDL-C) level of less than 70 mg/dL superior to a target LDL-C level of 90-110 mg/dL in prevention of future cardiovascular (CV) events in patients with a prior stroke of atherosclerotic origin or transient ischemic attack (TIA)?

  • 1
    News

    COVID-19 infection conveys imperfect immunity in young adults

    April 23, 2021

    One in 10 Marine recruits with prior SARS-CoV-2 infections were reinfected during basic training.

  • 1
    News

    COVID plus MI confers poor prognosis; 1 in 3 die in hospital

    April 22, 2021

    National registry data confirm the challenges and uniqueness of patients with STEMI and COVID-19, with atypical symptoms and ‘very high’ in-hospital mortality rates.

  • 1
    News

    Assessing the efficacy and safety of dapagliflozin in patients with HFrEF

    April 22, 2021

    Can the use of dapagliflozin, in addition to guideline-directed medical therapy, improve patient-reported outcomes and health-related quality of life in patients with heart failure and reduced ejection fraction (HFrEF)?

  • 1
    News

    Early palliative care consultation in the medical ICU

    April 21, 2021

    Does early palliative care consultation in critically ill patients lead to early establishment of code status and positively impact care?

Previous1 … 63 64 65 66 67 … 401Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences